Publicacións nas que colabora con Daniel Antonio González Padilla (4)

2024

  1. Chemoablation with UGN-102 in intermediate-risk non-muscle invasive bladder cancer, are we there yet?

    Translational Andrology and Urology

  2. First-line Management of Metastatic Urothelial Cancer: Current and Future Perspectives After the EV-302 and CheckMate-901 Studies

    Clinical Genitourinary Cancer

2022

  1. Recirculating hyperthermic intravesical chemotherapy with mitomycin C (HIVEC) versus BCG in high-risk non-muscle-invasive bladder cancer: results of the HIVEC-HR randomized clinical trial

    World Journal of Urology, Vol. 40, Núm. 4, pp. 999-1004

2021

  1. Quality of life and adverse events in patients with nonmuscle invasive bladder cancer receiving adjuvant treatment with BCG, MMC, or chemohyperthermia

    Urologic Oncology: Seminars and Original Investigations, Vol. 39, Núm. 1, pp. 76.e9-76.e14